Protagonist Therapeutics (PTGX)

• Market cap: $6.19B
• 1 day: 0.4%
• 5 days: 5.56%
• 1 month: 15.7%
• 3 months: 6.2%
• 6 months: 68.08%
• Year to date: 11.32%
• 1 year: 73.46%
• 5 years: 225.34%
• 10 years: 729.49%
• Sector: Healthcare
• Industry: Biotechnology

About: Protagonist Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of peptide-based therapeutics using its proprietary technology platform. The company focuses on three therapeutic areas: inflammation and immunology, hematology, and metabolic diseases. Its pipeline includes clinical-stage and preclinical candidates such as rusfertide for polycythemia vera, icotrokinra for inflammatory diseases, and other programs targeting IL-17, obesity, and iron metabolism disorders, developed through internal research and strategic collaborations.

Employees: 132